According to the Morbidity and Mortality Weekly Report, 67% of children who died with the new H1N1 flu virus had at least one high-risk medical condition. Any individual with an underlying respiratory condition such as asthma is more likely to experience serious health problems if he or she contracts the flu, according to the American Academy of Allergy, Asthma & Immunology (AAAAI). "As with seasonal influenza, people with chronic respiratory diseases such as COPD and asthma are more vulnerable to the adverse consequences of H1N1 infection. Recent data suggest that children with asthma are especially at risk and should heed the Centers for Disease Control and Prevention (CDC) recommendations regarding vaccination and treatment options, " said AAAAI Executive Vice President Thomas B.
MEDA Receives FDA Approval Of New ASTEPRO R azelastine HCl Nasal Spray 0.15 , The First And Only Once-Daily Nasal Antihistamine
Meda Pharmaceuticals Inc. announced that the US Food and Drug Administration (FDA) has approved ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15%, for the treatment of the symptoms of seasonal and perennial allergic rhinitis (SAR and PAR). New ASTEPRO Nasal Spray 0.15% is the first nasal antihistamine to offer convenient once-daily dosing for patients who suffer from seasonal allergies. ASTEPRO Nasal Spray 0.15% relieves rhinitis symptoms, including nasal congestion, without an added decongestant such as pseudoephedrine and is formulated with azelastine, a leading nasal antihistamine in the treatment of seasonal rhinitis in the U.S. The product will be available in pharmacies in early October.
As children head back to the classroom, Health Canada and the Canadian Food Inspection Agency are reminding parents of the importance of allergy awareness when packing lunches for their children. Severe allergic reactions can occur quickly and without warning, and some foods can be life-threatening to allergic children. As many as 1.2 million Canadians may be affected by allergies and these numbers are increasing, especially among children. Foods account for most children's allergies, with peanuts, tree nuts, sesame, soy, seafood (such as fish, crustaceans and shellfish), wheat, eggs and milk being the most common food allergens. When someone ingests even a tiny amount of an allergen, the symptoms of a reaction may develop quickly and can become very serious.
FDA Approves XYZAL R For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
UCB and sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has approved XYZAL(R) (levocetirizine dihydrochloride) for children age six months and older for the relief of symptoms of perennial allergic rhinitis (indoor allergies) and chronic idiopathic urticaria (chronic hives ) and for children age two years and older for symptoms of seasonal allergic rhinitis (outdoor allergies). Until now, XYZAL(R), a once-daily prescription antihistamine in both tablet and liquid formulations, has been used to treat symptoms of indoor and outdoor nasal allergies, as well as chronic idiopathic urticaria in patients age six years and older.
Burning candles made from paraffin wax - the most common kind used to infuse rooms with romantic ambiance, warmth, light, and fragrance - is an unrecognized source of exposure to indoor air pollution, including the known human carcinogens, scientists report. Levels can build up in closed rooms, and be reduced by ventilation, they indicated in a study presented at the 238th National Meeting of the American Chemical Society (ACS). In the study, R. Massoudi Ph.D., and Amid Hamidi, Ph.D., said that that candles made from bee's wax or soy, although more expensive, apparently are healthier. They do not release potentially harmful amounts of indoor air pollutants while retaining all of the warmth, ambience and fragrance of paraffin candles (which are made from petroleum).
Some children with a history of severe milk allergy can safely drink milk and consume other dairy products every day, according to research led by the Johns Hopkins Children's Center and published in the Aug. 10 online edition of the Journal of Allergy and Clinical Immunology. Investigators followed up with a subset of children who were part of an earlier Hopkins Children's-led study published in 2008 in which patients allergic to milk were given increasingly higher doses of milk over time. For many of them, continuous exposure to milk allergens the proteins that trigger bad reactions slowly and gradually retrained their immune systems to better tolerate the very food that once sent those systems into overdrive.